Harjit Gill, PhD

Upper Torso Vibroacoustic Stimulation for Treatment of No-Reflow Following STEMI-Directed PPCI: A Device and Pilot Study Protocol — Shake, Rattle, and Rock`n Reflow!

12/08/2016

Arkady Uryash , MD;

Harjit Gill , PhD;

Andrew Hoffmann , BSc;

We present a prospective, double-blinded, randomized, controlled pilot study protocol to test whether tdVAS (50 Hz, 2mm), by 30-minute session directly following primary percutaneous coronary intervention, is feasible, safe, and may enhance...

We present a prospective,...

12/08/2016

Cath Lab Digest

New Ideas

Can Upper Torso Vibro Acoustic Stimulation Treat No Reflow Following STEMI-Directed PPCI? Rationale and Literature Review. What’s the Buzzzzzzz?

09/05/2016

Arkady Uryash , MD;

Harjit Gill , PhD;

Andrew Hoffmann , BSc;

Low sonic vibroacoustic stimulation (VAS) has shown to enhance clot disruption and stimulate vasodilation. Moreover, transthoracic diastolic timed VAS (tdVAS) (50 Hz, 2 mm) has shown to enhance myocardial relaxation, improve left ventricular...

Low sonic vibroacoustic...

09/05/2016

Cath Lab Digest